A paucity of information exists regarding the presence of local renin-angiotensin systems (RASs) in skeletal muscle and associated muscle stem cells. Skeletal muscle and muscle stem cells were isolated from C57BL/6 mice and examined for the presence of a local RAS using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), immunohistochemistry (IHC), Western blotting and liquid chromatography-mass spectrometry (LC-MS). Furthermore, the effect of mechanical stimulation on RAS member gene expression was analysed. Whole skeletal muscle, primary myoblasts and C2C12 derived myoblasts and myotubes differentially expressed members of the RAS including angiotensinogen, angiotensin-converting enzyme (ACE), angiotensin II (Ang II) type 1 (AT 1 ) and type 2 (AT 2 ). Renin transcripts were never detected, however, mRNA for the 'renin-like' enzyme cathepsin D was observed and Ang I and Ang II were identified in cell culture supernatants from proliferating myoblasts. AT 1 appeared to co-localise with polymerised actin filaments in proliferating myoblasts and was primarily found in the nucleus of terminally differentiated myotubes. Furthermore, mechanical stretch of proliferating and differentiating C2C12 cells differentially induced mRNA expression of angiotensinogen, AT 1 and AT 2 . Proliferating and differentiated muscle stem cells possess a local stressresponsive RAS in vitro. The precise function of a local RAS in myoblasts remains unknown. However, evidence presented here suggests that Ang II may be a regulator of skeletal muscle myoblasts.
Introduction
The renin-angiotensin system (RAS) is a potent regulator of blood pressure and fluid homeostasis. Angiotensin II (Ang II), the end product of the RAS, is synthesised through enzymatic cleavage of angiotensinogen by renin to form angiotensin I (Ang I), which is subsequently cleaved by angiotensin-converting enzyme (ACE). 1 Recently, the notion that Ang II only arises through systemic sources has been challenged by detailed descriptions of local RASs in tissues such as lymphatic, digestive and adipose, as well as vascular and cardiac tissue. 2 Local RASs are characterised by tissue-specific expression of RAS family members, de novo Ang II synthesis and the potential to function independently or in concert with the systemic RAS. 2 Regrettably, the precise function of local RASs in peripheral tissues is not fully understood.
Mechanical stretch has been shown to be a potent activator of local RASs. In cultured cardiac myocytes, mechanical stimulation induced an upregulation of renin, angiotensinogen and ACE gene expression while also inducing the secretion of Ang II. 3 Similarly, mechanical stimulation via pressure overload of cardiac myocytes induced the upregulation of RAS family member expression in vivo and is hypothesised to mediate left ventricular hypertrophy. 4 Evidence of a similar stretch-responsive RAS has been reported in mesangial cells. Mechanical stretch of cultured mesangial cells induced a significant upregulation in angiotensin II type 1 (AT 1 ) receptor mRNA and Ang II binding while also increasing angiotensinogen mRNA and Ang II secretion. 5 Indirect evidence for a local RAS in skeletal muscle is accumulating. Ang II has been shown to be necessary for synergist ablation-induced compensatory hypertrophy, 6 and a lack of Ang II in muscle attenuated the addition of new myonuclei. 7 In spite of these results, it is not clear whether the effect of ACE inhibition utilised in these experiments, was due to local or systemic blockade of Ang II. Although it has recently been reported that skeletal muscle possesses ACE activity 8, 9 as well as de novo Ang I and II synthesis, 10 it is unclear if Ang II production occurs in skeletal muscle itself or through the associated microvascular bed. 11 To date, it is unknown whether a local RAS exists in mature skeletal muscle fibres and myogenic stem cells (satellite cells). Moreover, it is unknown whether a local RAS is responsive to mechanical stimulation similar to other myogenic lineages such as cardiac myocytes.
Methods

Animals
Ten-week-old male C57BL/6 mice were maintained on 12 h light-dark cycles and provided food and water ad libitum. Animals were euthanised by cervical dislocation and the tibialis anterior (TA) muscles were excised, snap frozen in liquid nitrogen and stored at -80°C. All procedures were conducted according to guidelines established by the Canadian Council on Animal Care with ethics approval from the McMaster University Research Ethics Board.
Cell culture
Primary myoblasts were isolated from the hind limbs of wild-type C57BL/6 mice as detailed previously. 12 Briefly, satellite cells were isolated via collagenase/dispase digestion of muscle followed by purification from fibroblasts through pre-plating. Experiments were only conducted after myoblasts had reached 99% purity. Cells were cultured at 37°C in 5% CO 2 in either proliferation media [proliferation medium (PM); F-10 supplemented with 20% fetal bovine serum (FBS), 1% penicillin-streptomycin and 2.5 ng/ml of basic fibroblast growth factor (bFGF)] or subsequently induced to differentiate in fusion media [fusion medium (FM); Dulbecco modified Eagle medium (DMEM) supplemented with 2% horse serum and 1% penicillinstreptomycin]. C2C12 myoblasts were grown at 37°C in 5% CO 2 in either growth media [growth medium (GM): DMEM supplemented with 10% FBS and 1% penicillinstreptomycin], FM or serum-free DMEM when indicated.
Immunohistochemistry (IHC)
Proliferating and terminally differentiated primary and C2C12 myoblasts were grown on gelatin-coated glass coverslips in PM, GM or FM respectively. Media was aspirated and coverslips were washed with phosphate-buffered saline (PBS), fixed in acetone for 10 min (for proliferating cells) or 4% paraformaldehyde (PFA) for 5 min and dehydrated in either ice-cold 100% ethyl alcohol (EtOH) (for terminally differentiated myotubes) or ice-cold acetone (co-staining) then again washed in PBS for 3 × 5 min. Coverslips were blocked for 1.5 h with 5% goat serum and 0.2% sodium azide in PBS followed by overnight incubation with primary antibodies for AT 1 or AT 2 at 1:100 dilution (SC-1173, SC-9040, respectively; Santa Cruz Biotechnologies, Santa Cruz, California, USA) or with simultaneous incubation with anti-AT 1 and tetrarhodamine isothiocyanate (TRITC)conjugated phalloidin (2 µg/ml, Sigma-Aldrich Canada Ltd., Oakville, Ontario, Canada) at 4°C in 2% goat serum. Coverslips where then washed for 3 × 5 min in PBS tween (PBST) followed by incubation with goat anti-rabbit Texas Red or Alexa 488 secondary antibodies (Molecular Probes, Invitrogen Canada Inc., Burlington, Ontario, Canada). After 3 × 5 min of washing in PBS, cells were counterstained with 4,6-diamino-2-phenylindole (DAPI) and coverslipped with mounting medium (Dako Canada, Inc., Mississauga, Ontario, Canada) and visualised on a Nikon Eclipse 90i.
RNA isolation, reverse transcription and quantitative real-time polymerase chain reaction
RNA was isolated from the TA muscle, proliferating C2C12 and primary myoblasts, differentiating C2C12 and primary myotubes or stretched proliferating and differentiating C2C12 cells using a combination of the TRIzol (Invitrogen Corporation, Carlsbad, California, USA) and the RNeasy method as per the manufacturer's instructions (Qiagen Inc., Valencia, California, USA). One thousand nanograms of total RNA from each sample was then reverse transcribed in 20 µl reactions according to the manufacturer's instructions (Applied Biosystems High Capacity cDNA Reverse Transcription Kit; Applied Biosystems, Life Technologies Corporation, Carlsbad, California, USA) and stored at -20°C. Quantitative real-time polymerase chain reactions (qRT-PCR) reactions were carried out using a Stratagene Mx3000P real-time PCR system (Stratagene, La Jolla, California, USA) using Stratagene MxPro QPCR software, version 3.00 (Stratagene, La Jolla, California, USA). Fold changes in gene expression were calculated using the delta-delta Ct method. 13 Primer sequences of genes analysed were as follows: for AT 1 , forward 5′-ACAG TGATATTGGTGTTCTCAATGAAA-3′ and reverse 5′-CCA TTGTCCACCCGATGAA-3′, for AT 2 , forward 5′-CAGAA TTACCCGTGACCAAG-3′ and reverse 5′-TAAACACACT GCGGAGCTT-3′, for angiotensinogen, forward 5′-GAGG CAAATCTGAGCAACATTG-3′ and reverse 5′-GAGTTC GAGGAGGATGCTATTGA-3′, for ACE, forward 5′-GTT CGTGGAAGAGTATGACCG-3′ and reverse 5′-CCATTG AGCTTGGCGAGCTTG-3′, for renin, forward 5′-TCTCT GGGCACTCTTGTTGCTCTG-3′ and reverse 5′-ATACGT CCCATTCAGCACTGAGCC-3′, for cathepsin D, forward 5′-ATCTTGGGCATGGGCTACC-3′ and reverse 5′-GGCT GGACACCTTCTCACAA-3′ and for ribosomal protein L32, forward 5′-TCCACAATGTCAAGGAGCTG-3′ and reverse 5′-ACTCATTTTCTTCGCTGCGT-3′.
Mechanical stretch
Actively growing C2C12 myoblasts or terminally differentiated myotubes were cultured on type I collagen-coated flexible-bottom plates [flex cell plates (Flexcell International, McKeesport, Pennsylvania, USA)] in GM or FM respectively. Proliferating cells were allowed to adhere for 12 h while myotubes were induced to fuse for 7 days prior to mechanical stimulation. The stretch protocol consisted of cyclic strain at 0.1 Hz (8 s of stretch alternated with 2 s of rest) of a 20% strain for a period of 4 h. 14 Stretch was applied using the FX-4000™ Tension Plus™ (Flexcell International, McKeesport, Pennsylvania, USA), a vacuum stretch apparatus coupled to computer software.
Liquid chromatography-mass spectrometry (LC-MS)
C2C12 myoblasts were grown for 24 h in DMEM without FBS and the supernatants were collected for LC-MS analysis. Solid-phase extraction (SPE) cartridges (Phenomenex Strata™-X, Torrence, CA, USA, 10 mg) were washed with 1 ml of methanol and 1 ml of water. Twenty microlitres of phosphoric acid was added to 1 ml of the sample. After loading, the cartridge was washed with 1 ml 20% acetonitrile and the sample eluted with 1 ml 80% acetonitrile. The eluant was dried and reconstituted in 100 µl 10% acetonitrile 0.1% formic acid. Samples were then run using an Agilent Poroshell 300SB-C18 (Mississauga, ONT, Canada) 2.1 × 75 mm column. Eluants were (A) 1% formic acid and (B) 1% formic acid in acetonitrile, with the following gradient program: initial A:B (95:5), hold 0.5 min, 3 min, A:B (60:40), 4 min, A:B (20:80). The following transitions were monitored: angiotensin II: 524à110 (45 V), angiotensin I: 433à110 (30 V) and leucine enkephalin (internal standard) 556à120 (45 V).
Nuclear and cytosolic protein fraction isolation and Western blotting
Nuclear and cytosolic protein fractions of terminally differentiated C2C12 cells were isolated using a commercially available kit (Pierce Biotechnology, Nepean, ONT, Canada) according to the manufacturer's instructions. Protein content was determined by the Bradford assay (Thermo Fisher Scientific Inc., Waltham, Massachusetts, USA) and loaded [10% of total protein for AT 1 and AT 2 or 10 µg for lactate dehydrogenase (LDH)] into a 10% polyacrylamide gel and resolved for 90 min at 100 V. Gels were transferred overnight at 50 V to polyvinylidene difluoride (PVDF) membranes, and equal loading was ensured through ponceau staining. Membranes were blocked in 5% skim milk in tris-buffered saline tween (TBST) for 2 h then incubated in primary antibodies [AT 1 (1:500), AT 2 (1:400) or LDH (1:2000); Cell Signalling Technology, Inc., Beverly, Massachusetts, USA)] for 2 h followed by 3 × 15 min of washing in 5% skim milk in TBST. Membranes were then incubated in horseradish peroxidase (HRP)-conjugated secondary antibody (1:25000 for AT 1 , AT 2 and 1:10000 for LDH) followed by 5 × 10 min washing in TBST and reaction with Pierce SuperSignal substrate (Pierce Biotechnology). Bands were visualised using the Alpha Innotech FluorChem SP and quantified using the AlphaEase software (Santa Clara, CA, USA).
Statistical analysis
Data was statistically analysed using the SigmaStat 3.1.0 analysis software (Systat, SPSS Inc., Chicago, Illinois, USA). Proliferation/differentiation mRNA expression was assessed by one-way ANOVA followed by Tukey's post hoc test. Western blots and mRNA expression from mechanically stimulated cells were analysed by t-tests. Statistical significance was accepted at p < 0.05.
Results
Adult skeletal muscle, myoblasts and differentiated myotubes express a local angiotensin signalling system
To examine if skeletal muscle fibres expressed members of the RAS, mRNA was isolated from the TA of C57BL/6 mice. The qRT-PCR analysis confirmed the expression of many RAS members including angiotensinogen, ACE, AT 1 and AT 2 (data not shown). Interestingly, the expression of renin was not detected despite probing with three sets of primers. As whole skeletal muscle contains many cell types (i.e. muscle cells, myoblasts, fibroblasts, endothelial cells), we wanted to investigate if RAS member expression was localised within actively proliferating or differentiating myogenic progenitor cells. Therefore, we analysed the expression of RAS members in two myogenic lineages: isolated primary myoblasts and C2C12 cells. In agreement with our in vivo findings, both proliferating primary and C2C12 myoblasts expressed mRNA transcripts for angiotensinogen, AT 1 and AT 2 (figure 1). When growth-arrested and induced to differentiate, RAS member genes were also detected and demonstrated a differential expression pattern. For example, both Ang II receptors demonstrated similar expression until terminal differentiation (day 7 for C2C12 cells, day 3 for primary myoblasts due to differing differentiation kinetics) when AT 1 increased significantly. Similarly, angiotensinogen significantly increased during differentiation when compared to proliferation (figure 1). Importantly, primary and C2C12 cells demonstrated similar gene expression patterning in both proliferating and differentiated cells. In further agreement with the in vivo analysis, renin transcripts were not expressed in either myoblasts or myotubes derived from primary or C2C12 cells. However, the expression of cathepsin D, an enzyme that is reported to possess 'renin-like' enzymatic action on angiotensinogen, 15 was detected in proliferating myoblasts and was significantly upregulated during differentiation (figure 1). Similarly, ACE was expressed in proliferating C2C12 myoblasts and was significantly upregulated upon differentiation, while ACE was only detected in terminally differentiated primary myotubes (figure 1) . We also probed for members of the 'extended' RAS including angiotensin-converting enzyme 2 (ACE2) and the MAS receptor but mRNA transcripts were not detected using multiple primer sets (data not shown).
AT 1 and AT 2 demonstrate differential localisation within muscle progenitors and differentiated myotubes
To confirm our qRT-PCR findings, we assessed primary myoblasts/myotubes and C2C12 cells at the protein level using IHC and Western blotting. We observed robust staining for AT 1 and AT 2 receptors in cultured primary and C2C12 myoblasts as well as differentiated myotubes (figures 2 and 3). In proliferating cells, AT 1 appeared to be predominately localised to cytoskeletal, filamentous proteins while AT 2 demonstrated a more diffuse expression pattern. Based on the appearance of AT 1 expression in both proliferating primary and C2C12 cells we conducted IHC co-staining to further define its location within the cell. Interestingly, co-staining of AT 1 and the actin marker, phalloidin, demonstrated many areas of co-localisation within the cell (figure 4) suggesting that AT 1 co-localised to cytoskeletal proteins. Furthermore, staining of terminally differentiated myotubes revealed that AT 1 also appeared to be localised within the myonucleus (figure 3 ). To confirm this observation we isolated nuclear and cytosolic fractions from terminally differentiated C2C12 cells. Indeed, Western blotting for the AT 1 receptor revealed that it was primarily expressed within a nuclear enriched fraction as an approximately 500% increase was observed in comparison to the cytosolic fraction ( figure 3C) . Interestingly, blotting also demonstrated that AT 2 only appeared to be localised within the cytosol ( figure 3F ). The purity of the nuclear/cytosolic preparation was confirmed by probing for the cytosolic specific marker LDH which only demonstrated expression within the cytosol (data not shown).
Cultured myogenic progenitor cells secrete angiotensins
To define myoblasts as possessing a local RAS, the cells must possess the ability to independently produce Ang II. Therefore, we assayed the ability of muscle myoblasts to produce angiotensins. In comparison to DMEM alone, LC-MS analysis of the cell culture supernatant of proliferating C2C12 cells revealed that myoblasts possess the ability to produce both Ang I and Ang II in culture within the 1.0-2.0 ng ml -1 range (figure 2E, F). 
Mechanical stretch alters the expression of genes associated with the RAS
As the expression of RAS members appeared to be stimulated by mechanical stretch in other local RASs, 4, 5, 16 we subjected proliferating myoblasts and differentiated myotubes to cyclic mechanical strain for 4 h. Mechanical stretch of both proliferating and differentiated C2C12 cells induced significant alterations in RAS member gene expression. In proliferating cells, angiotensinogen and both Ang II receptor subtypes demonstrated a significant upregulation 8 h poststretch, while no effect was observed on ACE (figure 5A-D) or cathepsin D expression (data not shown). Interestingly, 4 h of mechanical stretch induced differing effects on RAS member gene expression in terminally differentiated myotubes. Angiotensinogen demonstrated an early, significant increase in expression (4 h post-stretch, figure 5G) while the Ang II receptors demonstrated a reciprocal expression in response to mechanical stretch with AT 1 downregulated at 8 h post-stretch (figure 5E), while AT 2 was upregulated 4 h post-stretch ( figure 5F ). Conversely, ACE expression was not altered by mechanical stretch in terminally differentiated myotubes ( figure 5H ).
Discussion
The present manuscript describes definitive evidence for a local angiotensin signalling system in isolated primary and C2C12 cells. Recent investigations have provided initial evidence for the presence of such a system. For example, Qi et al., 17 using radioligand binding, demonstrated that human skeletal muscle myoblasts possess AT 1 and AT 2 receptors with AT 1 dominantly expressed. Furthermore, Mori et al. 18 reported that proliferating C2C12 cells possess ACE activity. However, the presence of other RAS members, or the ability of these cells to independently produce Ang II, was not assessed in these manuscripts. Additionally, there is a complete lack of data identifying a function for a local RAS in skeletal muscle. Although recent advances in the literature have delineated many of the transcriptional networks orchestrating muscle stem cell function, the upstream signalling events that induce these networks are largely undefined. The current manuscript provides evidence implicating a role for a local angiotensin system in regulating proliferating and differentiated muscle stem cells.
Our results indicate that muscle stem cells appear to possess a local angiotensin signalling system with the ability to secrete Ang I and II in vitro. Other local systems have been described to function in concert with the systemic RAS, 2 however, it is unknown whether the local RAS in skeletal muscle functions independently or in conjunction with the systemic RAS in vivo. Interestingly, C2C12 myoblasts were shown to possess the ability to secrete Ang I and II despite a lack of renin. This finding suggests that other enzymes function with renin-like enzymatic activity on angiotensinogen since this precursor peptide was identified in proliferating and differentiating cells. One candidate enzyme that demonstrated robust expression in proliferating and differentiating cells was cathepsin D. Cathepsin D has previously been shown to act on angiotensinogen 15 and is involved in the synthesis of Ang II in vascular smooth muscle cells (VSMCs) 19 as well as adipose tissue. 20 The differential localisation of AT 1 and AT 2 receptors in proliferating and differentiated cells suggests receptor specific function. Much recent literature has focused on the function of AT 1 signalling as it is thought to be the major receptor subtype involved in regulating Ang II action on VSMCs including vasoconstriction, proliferation and hypertrophy 21 as well as cardiac myocyte hypertrophy. 22 An increasing number of reports have demonstrated the presence and localisation of nuclear AT 1 receptors. Recent investigations observed AT 1 in the nucleus of human VSMCs, 23 human endocardial endothelial cells, 24 ventricular cardiomyocytes, 25 hepatocytes 26 and renal cells. 27 Although there is a paucity of information regarding the function of nuclear AT 1 receptors, initial reports suggest a role in regulating cellular proliferation. 28 Furthermore, Cook et al. 28 observed that targeting AT 1 to the nucleus by a novel fusion protein resulted in the activation of p38 MAPK and subsequent downstream activation of cyclic adenosine monophosphate response element-binding (CREB) protein.
The function of nuclear AT 1 receptors in muscle cells is completely unknown, but since skeletal muscle is terminally differentiated, signalling of Ang II through AT 1 would not promote cell division. Future investigations are needed to delineate its cellular function. IHC staining of angiotensin receptors in proliferating muscle stem cells also revealed differential localisation in the cell. In comparison to AT 2 , which demonstrated a heterogeneous staining pattern, AT 1 co-localised with the actin cytoskeleton in many areas. Although other cell surface receptors, such as the epidermal growth factor (EGF) receptor, have been demonstrated to associate with the actin cytoskeleton and the EGF receptor is an actin-binding protein, 29, 30 to our knowledge this is the first description of localised AT 1 with actin filaments in muscle stem cells. Interestingly, IHC staining also revealed areas where AT 1 and actin did not associate but were in close proximity suggesting that AT 1 may also co-localise with cytoskeletal adaptor proteins. 31 It should also be noted that although AT 1 and actin demonstrated IHC co-localisation, it is unknown whether there is physical association between these proteins through the cell membrane or if other proteins are required for this association. Along these lines, recent reports have suggested a role for caveolar lipid rafts in associating cell surface AT 1 with intracellular actin filaments through the protein filamin. 32 This AT 1 -caveolin relationship has been implicated in the regulation of tyrosine phosphorylation, reactive oxygen species (ROS) generation and signalling as well as VSMC growth and hypertrophy. 32 At present, the functional significance of this AT 1 -actin association in muscle stem cells is unknown. In other myogenic lineages, Ang II signalling through AT 1 has been shown to induce actin filament and cytoskeletal reorganisation 33, 34 and consequently influence cellular migration and chemotaxis of endothelial cells, 35 retinal microvascular pericytes 36 and VSMCs, 37 however, such a relationship has not been described in muscle stem cells.
In agreement with data from cardiomyocytes, 4, 16 mechanical stimulation of proliferating myoblasts and differentiated myotubes activated the local angiotensin signalling system in these cells. Mechanical stretch is a major component of skeletal muscle contraction and a significant regulator of muscle stem cell function. In vitro, stretch of muscle stem cells using a similar system has been demonstrated to activate other autocrine/paracrine signalling cascades, 14 increase cell proliferation 38 and inhibit differentiation. 39 Therefore, one could speculate that a local skeletal muscle and muscle stem cell angiotensin signalling system could become activated in response to muscle contraction in vivo. Interestingly, myoblasts and myotubes responded differently to mechanical stimulation. Of particular interest was the differential response of AT 1 expression in myoblasts (increasing expression) versus myotubes (decreasing expression). Since we demonstrated that terminally differentiated myotubes localised AT 1 to the nucleus, our results suggest that mechanical stimulation transiently decreases nuclear AT 1 production, the physiological consequences of which remain unknown. Ang II signalling through the AT 1 receptor has been shown to be essential for the growth associated with overload-induced muscle hypertrophy, 6 as well as the addition of myonuclei. 7 Functionally, in vivo overload and in vitro mechanical stretch represent different models as the latter lacks metabolic perturbation and therefore likely elicits a completely distinct cellular response. Furthermore, changes in mRNA may not directly affect cellular function as other factors such as receptor localisation (membrane/nucleus), 28 association with antagonising proteins 40 or activity of AT 2 signalling 41 have also been demonstrated to regulate this system. It should also be noted that the optimal duration and intensity of mechanical stimulation required for maximal activation of this system is unknown and manipulation of these factors could potentially yield differing results. However, additional experiments in our laboratory using 20 h of mechanical stretch demonstrated similar results with regards to changes in mRNA expression (data not shown).
Although it is not clear how blockade of Ang II production/signalling regulates muscle growth, it is reasonable to assume that muscle stem cells and post-mitotic fibres may be regulated, at least in part, by local Ang II. Ang II signalling through AT 1 could potentially regulate skeletal muscle growth through numerous mechanisms including enhancing muscle stem cell function (such as activation, chemotaxis, proliferation or differentiation) as well as effecting protein synthetic rate of post-mitotic fibres as AT 1 receptors were localised to both myoblasts and differentiated myotubes. Along these lines Ang II has been demonstrated to increase the proliferation and protein synthetic rate of other myogenic cell types such as VSMCs 42, 43 and cardiomyocytes. 44, 45 Interestingly, exogenous Ang II treatment of differentiated skeletal myotubes led to a 50% inhibition of protein synthesis 46 and protein degradation 47 in vitro. These seemingly disparate results suggest that, although necessary for overload-induced skeletal muscle hypertrophy, Ang II may function in a 'hormetic' fashion with chronic treatment resulting in net protein loss.
Conclusion
In summary, skeletal muscle derived stem cells possess a local angiotensin signalling system capable of producing Ang II despite the lack of renin. Interestingly, the AT 1 receptor was primarily expressed in the nucleus of differentiated myotubes and co-localised with actin filaments in proliferating cells. Furthermore, cyclic mechanical stimulation of both proliferating and differentiating muscle precursors differentially activated this system. Taken together, these results suggest a regulatory role of a local angiotensin signalling system in proliferating and differentiated muscle stem cells which merits further investigation.
